Last $37.42 USD
Change Today -0.92 / -2.40%
Volume 991.0K
MYGN On Other Exchanges
As of 4:00 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark H. Skolnick Ph.D.

Former Chief Scientific Officer and Director, Myriad Genetics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.



Mr. Mark H. Skolnick Ph.D. was a Scientific Founder of Myriad Genetics Inc. and served as its Chief Scientific Officer since 1997. Dr. Skolnick served as Executive Vice President of Research and Development of Myriad Genetics Inc. from 1991 to July 2000. Dr. Skolnick directed the group that cloned the breast cancer susceptibility gene, BRCA1; found the full-length sequence of BRCA2; cloned the MMAC1 (PTEN) tumor suppressor gene; cloned a prostate cancer gene (HPC2); ...

Read Full Background

Corporate Headquarters*

320 Wakara Way
Salt Lake City, Utah 84108

United States

Phone: 801-584-3600
Fax: 801-584-3640

Board Members Memberships*

Former Director
Former Chief Scientific Officer and Director
Former Director


Stanford University
PhD 1975
Stanford University
BA 1968
University of California
University of California Berkeley

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYGN:US $37.42 USD -0.92


Frank S. Hermance Chairman, Chief Executive Officer and Chairman of Executive Committee
Ametek Inc.
Jen-Hsun Huang Co-Founder, Chief Executive Officer, President and Director
NVIDIA Corporation
Moshe N. Gavrielov Chief Executive Officer, President and Director
Xilinx Inc.
Robert J. Stanzione Chairman and Chief Executive Officer
ARRIS Group, Inc.
Richard P. Wallace Chief Executive Officer, President and Executive Director
KLA-Tencor Corporation
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYRIAD GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at